Pablo Hernáiz-Driever

21PUBLICATIONS
106CO-AUTHORS
Neurology and neuromuscular diseasesRegenerative medicine (incl. stem cells)Molecular targetsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jan 27, 2026
Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II).

Pablo Hernáiz Driever, Uwe R Kordes, Ines B Brecht

|Jul 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.

Britt A E Dhaenens, Günter Heimann, Annette Bakker

|May 20, 2024
Rapid DNA methylation-based classification of pediatric brain tumors from ultrasonic aspirate specimens.

Michèle Simon, Luis P Kuschel, Katja von Hoff

|Nov 18, 2023
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford

|Jul 27, 2023
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas.

Romain Sigaud, Thomas K Albert, Caroline Hess

|Jun 01, 2023
Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies.

Sarah Weiß, Ulrich-Wilhelm Thomale, Matthias Schulz

Pageof 4

Frequent Collaborators

5 joint publications

Astrid Katharina Gnekow

5 joint publications

David Capper

5 joint publications

Jordan R Hansford

5 joint publications

Nicholas G Gottardo